Home
Browse
Search
Statistics
About
Usage
PMID: 21554546
Woodward OM, Kottgen A, Kottgen M
ABCG transporters and disease.
FEBS J. 2011 Sep;278(18):3215-25. doi: 10.1111/j.1742-4658.2011.08171.x. Epub 2011 Jun 13.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
59
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:59:1345
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 21554546:59:1246
status:
NEW
view ABCG2 p.Val12Met details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 21554546:59:1332
status:
NEW
view ABCG2 p.Ser441Asn details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 21554546:59:1320
status:
NEW
view ABCG2 p.Gln126* details
ABCG2 p.Gly268Arg
X
ABCG2 p.Gly268Arg 21554546:59:1326
status:
NEW
view ABCG2 p.Gly268Arg details
R L L A A M AT T T R V S G G G F I T Q R R V K K S G E A D RR V V K K L L G E E E I IN NN D H Q Q R V V V V V L L S G F E N M TT QD D S K R V K L L G F P C Y R K S G F P P C N N A V L L S G G G I N A D R K P P S GG G R V VK K KK L L L LL L S S S GG G PPE E IIII N NN M A A A T D D Y N E A I P E S I D L L F T LS G EI MT D I I P FC L R IH A N T T T T T G L D S S K K K L L L S G G G F F F F Q P P I M M A A A A D H G G LS S S V L L L L L R R RQ Q I I Y Y YS S HE E A T V V V V L Q I S F I I II A A L G G Y K F R S S E E I I L G Y YY Y V V K H S P C M M D R T I II L L L F F YV S S P F N T I A Q Q L L L G F Y Y H S S PR W C N M I I A A A L L G F V V K H W T L I F F C C C D D D A A A QQ Q Q Q G G G G G G G G G G FF FF F F FF Y Y Y Y Y V V V V V VVV K KKK KK K K E E E E P P P P R W W TT TT T TT T T NNNN N N N N N M MM M L L L L L L L L LL LL I I I I I I AA A A A A A S S S S S S S S SS L L L L LL L L LL V V F G GCC T Q Q Q Q Y Y Y KK K K K H H EE E E E E EEE E P P P P R R RW N N N II I I I I I I A AAA A A A S SS S S S S L L LL L L L V V V V F F F F F F F G GG G C TT T T T T K K K K KKKK N NN LL D DDD DS S 395 469 565 644 414 450 495 505 584 625 Signature Walker A WalkerBQ EP MI A V V VF FG GTN N NS S S S P F HE V FG CTT K NN LLD SS AAA I
V12M
N-terminus C-terminus M MM MM T A A A A L F F Y V V S S S F 524476 Y
Q126X
G268R
S441N
F506fs
Q141K
44 288 PP AA DD Fig. 2.
Login to comment
66
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:66:95
status:
NEW
view ABCG2 p.Gln141Lys details
We therefore investigated whether urate is a physiological substrate of ABCG2, and whether the
Q141K
variant, encoded by rs2231142, leads to altered urate transport and as a consequence to elevated serum urate levels and increased risk of gout.
Login to comment
81
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:81:0
status:
NEW
view ABCG2 p.Gln141Lys details
Q141K
is a functional variant in ABCG2 Several lines of evidence in the initial genome-wide association study by Dehghan et al. [21] suggested that the rs2231142 variant may be functional.
Login to comment
83
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:83:37
status:
NEW
view ABCG2 p.Gln141Lys details
Effect sizes of the ABCG2 rs2231142 (
Q141K
) variant on risk of gout and mean urate levels in study populations of different ancestry.
Login to comment
85
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:85:102
status:
NEW
view ABCG2 p.Gln141Lys details
the variant is located in exon 5 of ABCG2 and leads to a glutamine-to-lysine amino acid substitution (
Q141K
) in ABCG2.
Login to comment
90
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:90:98
status:
NEW
view ABCG2 p.Gln141Lys details
To test whether the rs2231142 is such a functional variant, the transport capacity of the encoded
Q141K
mutation was compared with that of wild-type ABCG2.
Login to comment
91
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:91:25
status:
NEW
view ABCG2 p.Gln141Lys details
Oocytes expressing ABCG2
Q141K
showed 54% reduced urate transport rates compared with oocytes expressing wild-type ABCG2 (Fig. 3C).
Login to comment
92
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:92:104
status:
NEW
view ABCG2 p.Gln141Lys details
This is consistent with previous studies showing impaired transport of chemotherapeutic agents by ABCG2
Q141K
[35,36] (and reviewed in [37]).
Login to comment
93
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:93:127
status:
NEW
view ABCG2 p.Gln141Lys details
While it is difficult to compare the results from different transport assays and substrates, the reduction of transport of the
Q141K
variant compared with wild-type ABCG2 appears to be of similar magnitude.
Login to comment
94
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:94:84
status:
NEW
view ABCG2 p.Gln141Lys details
The Q141 residue is located in the nucleotide binding domain of ABCG2 (Fig. 2), and
Q141K
ABCG2 expression is significantly lower than wild-type when overexpressed in mammalian cells [35,36,38,39].
Login to comment
96
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:96:13
status:
NEW
view ABCG2 p.Gln141Lys details
And like the
Q141K
ABCG2 mutation, expression of the deleted F508 CFTR mutant is significantly lower than wild-type suggesting a common pathophysiology (Woodward, unpublished observations).
Login to comment
97
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:97:232
status:
NEW
view ABCG2 p.Gln141Lys details
0.0 0.5 1.0 1.5 Urateaccumulation pmolperoocyte·120min-1 Urateaccumulation pmolperoocyte·120min-1 H2O ABCG2 ** A 0 20 40 60 0.4 0.6 0.8 1.0 Relativeurateremaining Time (min) ** ** ** ** ** B Lumen Blood 0.0 0.3 0.6 0.9 WT
Q141K
** C Others3 Others4 SLC2A9 URAT1 SLC2A9 Others1 Others2 UU- UU- UU-UU- UU- UU- UU- UU- U-UU- D ABCG2 Fig. 3.
Login to comment
101
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:101:86
status:
NEW
view ABCG2 p.Gln141Lys details
(C) Urate accumulation in oocytes expressing either the wild-type ABCG2 or the mutant
Q141K
ABCG2.
Login to comment
108
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:108:15
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 21554546:108:22
status:
NEW
view ABCG2 p.Gln126* details
In addition to
Q141K
,
Q126X
was identified as a novel loss-of-function variant.
Login to comment
109
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:109:49
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:109:140
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 21554546:109:0
status:
NEW
view ABCG2 p.Gln126* details
Q126X
was assigned to a different haplotype than
Q141K
and shown to increase gout risk (odds ratio 5.97) to an even greater extent than the
Q141K
variant.
Login to comment
110
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21554546:110:79
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 21554546:110:89
status:
NEW
view ABCG2 p.Gln126* details
In addition, 10% of the gout patients studied had genotype combinations of the
Q141K
and
Q126X
variants that resulted in more than a 75% reduction of ABCG2 function compared with patients that were homozygous for the non-risk allele at both variants (odds ratio 25.8, 95% confidence interval 10.3-64.6).
Login to comment